MedPath
FDA Approval

ARGATROBAN

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
February 1, 2021
Labeling Type
Human Prescription Drug Label
Argatroban(50 mg in 50 mL)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Caplin Steriles Limited

Caplin Steriles Limited

650744670

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

ARGATROBAN

Product Details

NDC Product Code
65145-126
Application Number
ANDA214235
Marketing Category
ANDA (C73584)
Route of Administration
INTRAVENOUS
Effective Date
February 1, 2021
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACT
Code: IY90U61Z3SClass: ACTIMQuantity: 50 mg in 50 mL
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3Class: IACT
ALCOHOLInactive
Code: 3K9958V90MClass: IACT
© Copyright 2025. All Rights Reserved by MedPath